International Sickle Cell Day 2026

#GS-2 #Health #Vulnerable Sections #National #Economy

Why in News

On International Sickle Cell Day 2026, the President reaffirmed India's target to eliminate sickle cell anaemia before 2047.
This goal operates under the National Sickle Cell Anaemia Elimination Mission.
The President marked this commemoration at Omkareshwar, Madhya Pradesh, celebrating a significant health milestone.

The world observes International Sickle Cell Day every year on 19th June to raise awareness about the disease.
This day promotes early diagnosis, proper treatment, and effective prevention of sickle cell disease.
The United Nations General Assembly officially recognized this day through a resolution adopted on 22nd December 2008.
The resolution described sickle cell disease as a major public health problem and a vital global genetic disease.
The theme for 2026 is Closing the Survival Gap: Equity in Sickle Cell Disease.
This theme emphasizes bridging existing disparities and uniting local and global communities to support patients.

Sickle Cell Disease is a group of inherited, chronic blood disorders affecting the body.
It alters the structure of hemoglobin, which is the vital protein inside red blood cells that carries oxygen.
Instead of remaining flexible and round, affected red blood cells mutate into rigid, crescent, or sickle shapes.
It is caused by a structural mutation in the HBB gene, which gives instructions for making beta-globin.
The disease follows an autosomal recessive inheritance pattern.
A person develops the disease only if they inherit two abnormal hemoglobin genes from both parents.
Individuals inheriting only one mutated gene copy are called carriers or possess the Sickle Cell Trait.
Carriers generally live healthy lives without symptoms but can pass the mutated gene to their biological children.

Abnormal red blood cells become rigid and sticky, reducing their ability to flow smoothly through blood vessels.
This leads to blocked circulation and a severe disruption in oxygen supply throughout the body.
Vaso-occlusive crises happen when sickle cells block small blood vessels, causing intense pain and tissue damage.
Rapid destruction of sickle cells results in chronic anaemia, persistent fatigue, breathlessness, and weakness.
Repeated spleen injury reduces overall immunity, making patients vulnerable to serious infections.
Long-term oxygen deprivation causes progressive damage to the brain, lungs, kidneys, and other vital organs.
Symptoms usually appear around 5 to 6 months of age as fetal hemoglobin levels decline.

The National Sickle Cell Anaemia Elimination Mission launched in 2023 to address the heavy disease burden.
The mission specifically targets tribal populations and aims for total elimination by 2047.
The government implements this mission under the National Health Mission across 17 high-focus states.
It focuses heavily on early detection, proper treatment, public awareness, and disease prevention.
The mission adopts a mission-mode approach combining large-scale screening and community awareness.
It targets approximately 7 crore people aged 0 to 40 years over a span of three years from 2023 to 2026.
The Ministry of Health and Family Welfare and the Ministry of Tribal Affairs jointly implement this mission.

Pain management uses analgesics, anti-inflammatory drugs, and proper hydration to control severe crises.
Hydroxyurea therapy increases fetal hemoglobin production to reduce cell sickling and pain episodes.
Regular antibiotics and vaccination prevent severe infections, particularly in infants and young children.
Doctors use blood transfusions to reduce dangerous complications such as stroke and severe anaemia.